There are two types of<unk> : small-cell and large-cell. Small-cell carcinoma (SCC) Small-cell carcinoma (SCC) of the cervix is an exceptional member of the<unk>  group of cervical carcinomas that is frequently intermixed with a non-SCC component in the form of an adenocarcinoma (ADC) or squamous carcinoma. SCC is an aggressive tumor that spreads very quickly early on; this leads to a fatal clinical course and minimal chances of survival for the patients. It resembles small-cell cancer of the lungs and accounts for less than 3% of all cervical cancers. Like small-cell cancer in the lungs, the lymph nodes play a major role in spreading the cancer throughout the body. SCC begins in the inner part of the cervix and is very hard to diagnose. Due to the involvement of the lymph nodes, in its late and fatal stages, it can spread beyond the pelvic region to other organs. The prevalence of the lymph nodes involvement and that systemic metastasis is much higher in SCC than in non-SCC, thus more complex treatments are required for SCC. “Because of the distinct natural history of small cell carcinoma of the uterine cervix, and because patients with this condition are considered to have a systemic disease, the treatment strategies for this disease are different from those of other carcinomas” (ajronline.org). According to a report (Yang, et al. 2003), multi-agent chemotherapy and pelvic radiotherapy before surgery (radical hysterectomy) followed by chemotherapy after surgery produce better outcomes for its patients. Unfortunately, Pap smears alone are not adequate for the diagnosis of SCC; patients may be misdiagnosed with non-SCC on the basis of Pap smear results alone. Imaging studies are necessary for proper diagnosis; it has been proposed that MRI is the highest standard for the imaging evaluation of uterine cervical cancer. The major problem with early accurate diagnosis of SCC is the limitation of routine screening, namely the Pap smear. Large-cell carcinoma (LCC) Large-cell carcinoma (LCC), like small-cell carcinoma (SCC) is very rare and only accounts for about 5% of all cervical cancers. Early-stage LCC are extremely aggressive and difficult to diagnose due to the sub-mucosal location of the tumor and intact overlying mucosa. As with SCC, in LCC early cases are asymptomatic. Later stages present with irregular bleeding, vaginal spotting, discharge, and pelvic pain. The basis for treatment of LCC tumors is derived from therapy used for SCC; when diagnosed, multimodal therapy should be considered just as with SCC.
Neuroendocrine carcinoma of the cervix
Glassy cell carcinoma of the cervix
Squamous-cell carcinoma of the vagina
Clear-cell adenocarcinoma of the vagina
Villoglandular adenocarcinoma of the cervix
Endometrial stromal sarcoma
Endometrial stromal tumour
Vaginal melanoma